Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Virus Genes ; 55(3): 406-410, 2019 Jun.
Article in English | MEDLINE | ID: mdl-30758769

ABSTRACT

The respiratory syncytial virus (RSV) is the main pathogen associated with upper respiratory tract infections during early childhood. Vertical transmission of this virus has been suggested in humans, based on observations recorded during animal studies that revealed an association of RSV with persistent structural and functional changes in the developing lungs of the offspring. However, human placentas have not yet been evaluated for susceptibility to RSV infection. In this study, we examined the capacity of RSV to infect a human trophoblast model, the BeWo cell line. Our results suggest that BeWo cells are susceptible to RSV infection since they allow RNA viral replication, viral protein translation, leading to the production of infectious RSV particles. In this report, we demonstrate that a human placenta model system, consisting of BeWo cells, is permissive to RSV infection. Thus, the BeWo cell line may represent a useful model for studies that aim to characterize the events of a possible RSV infection at the human maternal-fetal interface.


Subject(s)
Cell Line, Tumor/virology , Choriocarcinoma/virology , Respiratory Syncytial Virus Infections/genetics , Respiratory Syncytial Viruses/genetics , Choriocarcinoma/complications , Choriocarcinoma/genetics , Female , Humans , Placenta/pathology , Placenta/virology , Pregnancy , RNA, Viral/genetics , Respiratory Syncytial Virus Infections/complications , Respiratory Syncytial Virus Infections/virology , Respiratory Syncytial Viruses/pathogenicity
2.
Clin Exp Allergy ; 44(5): 673-80, 2014.
Article in English | MEDLINE | ID: mdl-24245689

ABSTRACT

BACKGROUND: Sputum eosinophil counts and eosinophil cationic protein (ECP) levels are usually increased in asthmatic patients. The correlation between sputum eosinophils or ECP and clinical findings of asthma has been previously investigated but many of these studies have been performed on small samples of asthmatic patients, considering only few clinical indices and often including patients on oral or inhaled corticosteroids, which might be confounding when interpreting the relationship between disease activity and airway inflammation. OBJECTIVE: To assess whether sputum eosinophils and ECP were differently related to functional and clinical parameters of asthma in a large number of steroid-naïve asthmatic patients, taking into account several potential determinants of activity and chronicity of asthma. METHODS: One hundred and twenty-nine patients with mild-moderate asthma were studied. Sputum was induced by hypertonic saline inhalation and processed using the whole sample method. RESULTS: Sputum eosinophils and ECP significantly correlated with each other (r = 0.41, P < 0.001). When patients were grouped on the basis of high/low sputum eosinophils and high/low sputum ECP levels, significant differences were observed among groups, with patients with high sputum eosinophils and ECP showing the greatest asthma severity. In the overall sample, disease duration inversely correlated with sputum eosinophils, whereas FEV1 and peak expiratory flow (PEF) inversely correlated with sputum ECP. Rescue ß2 -agonist use and total symptom score positively correlated with both eosinophil counts and sputum ECP. Stepwise regression analysis showed that symptom score and disease duration accounted for 17.6% of sputum eosinophil variance, whereas symptom score and FEV1 accounted for 14.7% of sputum ECP variance. CONCLUSIONS AND CLINICAL RELEVANCE: Both sputum eosinophils and ECP are weakly related to clinical markers of asthma severity. However, ECP was more closely related to lung function parameters than eosinophil counts.


Subject(s)
Asthma/immunology , Asthma/metabolism , Eosinophil Cationic Protein/metabolism , Eosinophils/immunology , Eosinophils/metabolism , Adult , Asthma/diagnosis , Female , Humans , Leukocyte Count , Male , Middle Aged , Respiratory Function Tests , Retrospective Studies , Risk Factors , Sputum/cytology , Sputum/immunology , Young Adult
3.
Clin Exp Allergy ; 37(12): 1819-26, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17941910

ABSTRACT

BACKGROUND: Hypertonic saline (HS) has been shown to modulate in vitro cell functions according to the state of cell activation; however, few studies have evaluated the effect of HS in vivo. Chronic airway inflammation, a major feature of chronic obstructive pulmonary disease (COPD), is associated with an activation of inflammatory and resident cells, which in turn makes them more prompt to respond to further stimuli. OBJECTIVE: To evaluate whether HS might modulate, also in vivo, the release of preformed mediators and intracellular chemokines from airway cells of COPD patients. METHODS: Sputum was induced by inhalation of either HS (4.5% w/v) or isotonic saline (IS 0.9% w/v) solution and processed by plug selection. We measured eosinophil cationic protein (ECP), neutrophil elastase (NE), IL-8 and monocyte chemoattractant protein-1 (MCP-1) in sputum samples obtained by either HS or IS inhalation in 24 COPD patients. RESULTS: No significant difference in mediators measured in sputum samples obtained by the two different inductions was observed; also, there was no significant difference in sputum sample volumes, cell viability, total and differential cell counts. Repeatability between the two tests was high for ECP, NE, macrophages, neutrophils and eosinophils, and satisfactory for IL-8 and MCP-1. CONCLUSIONS: Hyperosmolarity does not affect the levels of the inflammatory mediators and chemokines examined or the cell counts measured in induced sputum obtained from COPD patients. This study does not support the hypothesis that HS can stimulate chemokine and mediator release from airway cells of COPD patients. Therefore, HS and IS can be interchangeably used to measure inflammatory mediators in the sputum supernatant of COPD patients.


Subject(s)
Chemokines/metabolism , Isotonic Solutions/pharmacology , Pulmonary Disease, Chronic Obstructive/metabolism , Saline Solution, Hypertonic/pharmacology , Sputum/drug effects , Sputum/metabolism , Aged , Chemokines/biosynthesis , Female , Humans , Inhalation , Isotonic Solutions/administration & dosage , Male , Pulmonary Disease, Chronic Obstructive/physiopathology , Saline Solution, Hypertonic/administration & dosage , Solubility
4.
Eur Respir J ; 24(6): 1018-24, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15572548

ABSTRACT

The aim of this study was to assess whether hyperosmolarity affects granulocyte mediator levels in induced sputum of asthmatic subjects. A total of 32 mild-to-moderate asthmatics, who inhaled either hypertonic (HS; 4.5% NaCl) or isotonic (IS; 0.9% NaCl) solutions for 15 min, were studied. Selected sputum was used for analysis. Eosinophil cationic protein (ECP), eosinophil protein X (EPX), myeloperoxidase (MPO) and free neutrophil elastase (NE) were measured in sputum supernatant. Sample weight, total and differential cell counts, as well as viability and squamous cell percentage were no different after the two tests. No significant differences in ECP, EPX, MPO or NE levels were observed between HS- and IS-induced sputum. Repeatability of the two tests was good for macrophages, neutrophils, eosinophils, ECP, EPX and NE, but not for lymphocytes and MPO. In conclusion, hyperosmolarity does not affect sputum cell counts and the levels of most granulocyte degranulation markers examined in this study, confirming that both hypertonic and isotonic solutions can be reliably used to induce sputum in asthmatics.


Subject(s)
Asthma/metabolism , Granulocytes/metabolism , Sputum/chemistry , Administration, Inhalation , Asthma/physiopathology , Cell Count , Eosinophil Cationic Protein/metabolism , Eosinophil-Derived Neurotoxin/metabolism , Female , Forced Expiratory Volume , Humans , Isotonic Solutions/administration & dosage , Leukocyte Elastase/metabolism , Male , Middle Aged , Peroxidase/metabolism , Reproducibility of Results , Saline Solution, Hypertonic/administration & dosage , Sodium Chloride/administration & dosage , Sputum/cytology
5.
Bioorg Med Chem Lett ; 10(17): 1975-8, 2000 Sep 04.
Article in English | MEDLINE | ID: mdl-10987430

ABSTRACT

A series of substituted 2-aminopyridines was prepared and evaluated as inhibitors of human nitric oxide synthases (NOS). 4,6-Disubstitution enhanced both potency and specificity for the inducible NOS with the most potent compound having an IC50 of 28 nM.


Subject(s)
Aminopyridines/chemical synthesis , Enzyme Inhibitors/chemical synthesis , Nitric Oxide Synthase/antagonists & inhibitors , Aminopyridines/pharmacology , Enzyme Inhibitors/pharmacology , Humans , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...